BioScrip sales increase, profits decrease in Q3

ELMSFORD, N.Y. — Specialty pharmacy provider BioScrip reported $454 million in sales and $500,000 in profits in third quarter 2011, according to an earnings statement released Tuesday.



The sales figure represented a 2.9% increase over third quarter 2010's $441.2 million, while the profits compared with profits of $2 million during the same period a year ago.



"Overall, growth occurred in spite of a challenging economic environment impacting demand for services, lower acuity levels, shifts in reimbursement rates and other short-term trends impacting companies industry wide," BioScrip president and CEO Rick Smith said. "The diversification that we have in our payer mix has enabled us to keep making forward progress."

Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.